Kieran O'Kane Biodesix Inc (BDSX) insider trading activity

BDSX Quotes by TradingView

Kieran O'Kane is Chief Commercial Officer of BIODESIX INC. Currently has a direct ownership of 89,628 shares of BDSX, which is worth approximately $157,745. The most recent transaction as insider was on Aug 12, 2024, when has been sold 120 shares (Common Stock) at a price of $1.57 per share, resulting in proceeds of $188. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 89.6K
1.16% 3M change
91.96% 12M change
Total Value Held $157,745

Kieran O'Kane Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 12 2024
SELL
Open market or private sale
$188 $1.57 p/Share
120 Reduced 0.13%
89,628 Common Stock
Aug 09 2024
SELL
Open market or private sale
$552 $1.6 p/Share
345 Reduced 0.38%
89,748 Common Stock
Aug 08 2024
BUY
Exercise of conversion of derivative security
-
1,489 Added 1.63%
90,093 Common Stock
May 23 2024
BUY
Exercise of conversion of derivative security
-
13,080 Added 12.86%
88,604 Common Stock
May 09 2024
SELL
Open market or private sale
$692 $1.48 p/Share
468 Reduced 0.62%
75,524 Common Stock
May 08 2024
BUY
Exercise of conversion of derivative security
-
1,489 Added 1.92%
75,992 Common Stock
Feb 12 2024
SELL
Open market or private sale
$8,983 $1.66 p/Share
5,412 Reduced 7.37%
68,005 Common Stock
Feb 09 2024
SELL
Open market or private sale
$12,132 $1.92 p/Share
6,319 Reduced 7.92%
73,417 Common Stock
Feb 08 2024
BUY
Exercise of conversion of derivative security
-
32,024 Added 28.65%
79,736 Common Stock
Nov 10 2023
SELL
Open market or private sale
$289 $1.23 p/Share
235 Reduced 0.49%
47,712 Common Stock
Nov 09 2023
SELL
Open market or private sale
$297 $1.27 p/Share
234 Reduced 0.49%
47,947 Common Stock
Nov 08 2023
BUY
Exercise of conversion of derivative security
-
1,489 Added 3.0%
48,181 Common Stock
Aug 10 2023
SELL
Open market or private sale
$1,078 $1.27 p/Share
849 Reduced 1.79%
46,692 Common Stock
Aug 09 2023
SELL
Open market or private sale
$1,181 $1.39 p/Share
850 Reduced 1.76%
47,541 Common Stock
Aug 08 2023
BUY
Exercise of conversion of derivative security
-
5,462 Added 10.14%
48,391 Common Stock
Aug 03 2023
BUY
Grant, award, or other acquisition
$9,998 $1.62 p/Share
6,172 Added 12.57%
42,929 Common Stock
May 10 2023
SELL
Open market or private sale
$748 $1.58 p/Share
474 Reduced 1.27%
36,757 Common Stock
May 09 2023
SELL
Open market or private sale
$1,920 $1.57 p/Share
1,223 Reduced 3.18%
37,231 Common Stock
May 08 2023
BUY
Exercise of conversion of derivative security
-
5,461 Added 12.44%
38,454 Common Stock
Feb 09 2023
SELL
Open market or private sale
$3,598 $1.8 p/Share
1,999 Reduced 8.0%
22,993 Common Stock
Feb 08 2023
BUY
Exercise of conversion of derivative security
-
5,461 Added 17.93%
24,992 Common Stock
Nov 21 2022
BUY
Grant, award, or other acquisition
$4,999 $1.15 p/Share
4,347 Added 18.21%
19,531 Common Stock
Nov 10 2022
SELL
Open market or private sale
$768 $1.02 p/Share
753 Reduced 4.72%
15,184 Common Stock
Nov 09 2022
SELL
Open market or private sale
$990 $1.04 p/Share
952 Reduced 5.64%
15,937 Common Stock
Nov 08 2022
BUY
Exercise of conversion of derivative security
-
5,461 Added 24.43%
16,889 Common Stock
KO

Kieran O'Kane

Chief Commercial Officer
Boulder, CO

Track Institutional and Insider Activities on BDSX

Follow BIODESIX INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BDSX shares.

Notify only if

Insider Trading

Get notified when an Biodesix Inc insider buys or sells BDSX shares.

Notify only if

News

Receive news related to BIODESIX INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on BDSX